Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation

David-A Mendels,Laurent Dortet,Cécile Emeraud,Saoussen Oueslati,Delphine Girlich,Jean-Baptiste Ronat,Sandrine Bernabeu,Silvestre Bahi,Gary J H Atkinson,Thierry Naas,David-A. Mendels,Gary J. H. Atkinson
DOI: https://doi.org/10.1073/pnas.2019893118
IF: 11.1
2021-03-05
Proceedings of the National Academy of Sciences
Abstract:Serological rapid diagnostic tests (RDTs) are widely used across pathologies, often providing users a simple, binary result (positive or negative) in as little as 5 to 20 min. Since the beginning of the COVID-19 pandemic, new RDTs for identifying SARS-CoV-2 have rapidly proliferated. However, these seemingly easy-to-read tests can be highly subjective, and interpretations of the visible “bands” of color that appear (or not) in a test window may vary between users, test models, and brands. We developed and evaluated the accuracy/performance of a smartphone application (xRCovid) that uses machine learning to classify SARS-CoV-2 serological RDT results and reduce reading ambiguities. Across 11 COVID-19 RDT models, the app yielded 99.3% precision compared to reading by eye. Using the app replaces the uncertainty from visual RDT interpretation with a smaller uncertainty of the image classifier, thereby increasing confidence of clinicians and laboratory staff when using RDTs, and creating opportunities for patient self-testing.
multidisciplinary sciences
What problem does this paper attempt to address?